News

Updated version of the methodology: the European Partnerships for Health

As of 1 November 2024, the Agency for Health Research ČR has published the second working version of the "European Partnerships for Health" methodology. This updated version extends the first version with the latest information and advances in each European Health Partnership. In addition, it provides details on national...

ERA4Health Partnership: a pilot call for clinical trials is about to be announced!

A key effort of the ERA4Health partnership (Fostering a European Research Area for Health) is to create flexible and efficient coordination between funding organisations in the European Research Area (ERA) in priority areas addressing European public health needs. This partnership provides an opportunity to increase the European transnational common...

Call for nominations to the ERDERA Advisory Board

An opportunity to get involved in shaping the future of rare disease research is offered by the European Rare Diseases Research Alliance (ERDERA), which has launched a process to establish a Multistakeholder Advisory Board (MAB). This board will play a key role in providing...

Change of the date for the announcement of the next public tender

We would like to inform you that the next call for tenders (VES 2026) will be announced so that the supported projects can be implemented as early as 1 January 2026, i.e. within the duration of 48 months. We expect to announce VES 2026 in the first week of February,...

Professor Pavel Klener died

It is with deep regret that we have received the news of the death of Prof. Pavel Klener, MD, DrSc., a top hematologist, oncologist, scientist and educator, who was also a long-time collaborator of the Agency for Medical Research ČR.

Advance notice of forthcoming European Health Partnership calls

The Department of Health/Health Research Agency ČR are planning to participate in upcoming calls, to be launched in November and December 2024, under the four European Health Partnerships: The call texts for the above mentioned partnerships are currently being commented. The final texts of these...